Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing.
Mayo Clin Proc. 2018 01;93(1):113-120
Authors: Allyse MA, Robinson DH, Ferber MJ, Sharp RR
Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0.
PMID: 29304915 [PubMed – indexed for MEDLINE]